静脉利多卡因输注与胸段硬膜外镇痛在腹部大手术中的疗效:非劣效性随机临床试验
这项非劣效性随机临床试验纳入210例腹部大手术患者,比较静脉利多卡因与胸段硬膜外布比卡因复合吗啡的镇痛效果。术后24小时动态疼痛评分差值0.53(95%CI 0.0-1.0),在预设非劣效界值1以内;静脉利多卡因组吗啡消耗量平均多1.8 mg(95%CI 1-3 mg)。结论为静脉利多卡因在术后24小时急性疼痛控制方面非劣效于胸段硬膜外镇痛,不良事件无差异。
要点
- 静脉利多卡因在腹部大手术后24小时动态疼痛控制上非劣效于胸段硬膜外镇痛。
- 静脉利多卡因组24小时吗啡消耗量平均多1.8 mg(95%CI 1-3 mg)。
- 两组操作相关不良事件或并发症无差异。
核心结论
- 在腹部大手术术后24小时急性疼痛控制中,静脉利多卡因非劣效于胸段硬膜外镇痛。
研究设计与样本
- 非劣效性随机临床试验,共纳入210例接受腹部大手术的患者,随机分配至胸段硬膜外布比卡因复合吗啡组或静脉利多卡因组。
主要发现
- 静脉利多卡因组术后24小时动态疼痛数字评分(NPR)为5.7(1.8),硬膜外组为5.2(1.9),差值0.53(95%CI 0.0-1.0)。
- 术后第一个24小时,静脉利多卡因组与硬膜外组的吗啡消耗量平均差值为1.8 mg(95%CI 1-3 mg)。
- 两组操作相关不良事件或并发症无差异。
关键数值与推荐
- 动态疼痛NPR差值≤1被设为非劣效界值。
- 主要结局为术后24小时动态疼痛NPR。
临床怎么用
- 对于腹部大手术术后急性疼痛,静脉利多卡因可作为胸段硬膜外镇痛的替代方案。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Open major abdominal surgery is one of the most risky surgical procedures for acute postoperative pain. Thoracic epidural analgesia (TEA) has been considered the standard analgesic approach. In different reports, lidocaine i.v. has been shown to have an analgesic efficacy comparable with TEA. We compared the analgesic efficacy of i.v. lidocaine with thoracic epidural analgesia using bupivacaine in patients undergoing major abdominal surgery. METHODS: In this noninferiority clinical trial, 210 patients were randomised to thoracic epidural bupivacaine with morphine or i.v. lidocaine. Dynamic pain at 24 h after surgery was measured using a numerical pain rating scale (NPR), and morphine consumption was also measured. A difference in i.v. the lidocaine-epidural bupivacaine NPR of ≤1 for dynamic pain was considered a noninferiority margin. RESULTS: The NPR for dynamic pain in the lidocaine group at 24 h was between 5.7 (1.8) and 5.2 (1.9) in the epidural group, with a difference of 0.53 (95% confidence interval 0.0-1.0). In the first 24 h, the average difference in morphine consumption was 1.8 mg between the i.v. lidocaine and epidural groups (95% confidence interval 1-3 mg). No differences were found in adverse events or complications associated with the procedures. CONCLUSIONS: Intravenous lidocaine is noninferior to thoracic epidural analgesia for acute postoperative pain control in major abdomial surgery at 24 h postoperatively. CLINICAL TRIALS REGISTRATION: NCT04017013.
引用
- Casas-Arroyave FD, Osorno-Upegui SC, Zamudio-Burbano MA, et al. Therapeutic efficacy of intravenous lidocaine infusion compared with thoracic epidural analgesia in major abdominal surgery: a noninferiority randomised clinical trial. Br J Anaesth. 2023. PMID: 37758623. doi:10.1016/j.bja.2023.07.032
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。